Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-29 @ 6:00 PM
Study NCT ID:
NCT01581658
Status:
COMPLETED
Last Update Posted:
2017-08-14
First Post:
2012-04-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2012-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-17
First Submit QC Date:
None
Study First Post Date:
2012-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-16
Results First Submit QC Date:
None
Results First Post Date:
2014-06-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-04
Last Update Post Date:
2017-08-14
Last Update Post Date Type:
ACTUAL